May 28, 2020

Labcorp accelerates adoption of decentralized clinical trials, expands technology ecosystem through alliance with Medable

BURLINGTON, N.C. --(BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.